My Sunday pre-conference Provider Symposium post is here.
So, I'm home. Left the Convention Center at 1:32 and beat the 680 crush. Home by 3, too tired to do anything.
Gonna now triage my myriad shots and begin uploading them. Then I'll review my copious notes and post my conference takeaways. Lots of great stuff.
Indu set the "looking ahead" agenda at the outset, citing "Five Drivers" going forward:In the interim, before I riff on more detail, I recommend to everyone this poignant THCB post. Reminds me of this one. I totally personally relate to the latter one, given my daughter's Stage IV pancreatic cancer dx.
- FHIR and Blockchain;
- New modalities and analytics;
- New entrants into healthcare, large and small;
- Incumbents adopting new stripes;
- New environments for health care.
Stay tuned. Hundreds of shots to review.
But, first, a divergence apropos of HIT, breaking news from STAT:
IBM to Congress: Watson will transform health care, so keep your hands off our supercomputerSee my prior post "Watson and cancer." FierceHealthIT is also on the story.
To the public, IBM trumpets its Watson supercomputer as the next big thing in medicine, a new kind of machine that melds human expertise with digital speed to give patients personalized treatment advice.
Meanwhile, in the halls of Congress, company executives have been delivering a blunter message: We will revolutionize patient care, so please get out of the way.
Like any new technology, Watson poses unknown risks; for example, what if its advice is wrong and harms a patient? But IBM argues that its machine doesn’t need to be regulated because it’s different from other medical devices. It’s not like a pacemaker or a CT scanner, so the company shouldn’t have to prove to the government that it’s safe and effective.
Now, as federal regulators prepare to weigh in on that issue, a STAT examination shows the lengths to which IBM has gone to shield its prized machine from government scrutiny.
The company’s fingerprints are all over legislation passed last year that exempted several types of health software from FDA jurisdiction…
MORE PICS...
HIMSS in the House, Hal Wolf and Stephen Lieber. |
HLA Global in the House, Jon Patrick and son. |
Triple threat opening Keynotes: Bruce Greenstein, Aneesh Chopra, and David Brailer.
More pics...
Gil Addo, CEO, RubiconMD |
Amy Abernethy, MD PhD, CMO, Flatiron |
Sandra Hernandez, MD, President & CEO, California Health Care Foundation |
CONTINUING
Major Underachiever |
Indu interviews RWJF's Dr. Michael Painter |
I got invited to the Tuesday evening Aetna private reception. Nice. Thanks. |
A long day. A ton to assimilate. More shots below coming shortly.
UPDATE
The shutter clicks continue.
I have more, LOL, but you get the idea. Yet another great Health 2.0 Conference. Gotta now spend some time pondering my notes.
UPDATE
MobiHealthNews has excellent comprehensive coverage up.
In-Depth: News and views from Health 2.0 2017I can't top that. Read all of it. Kudos.
This year was the 11th anniversary of Health 2.0, a yearly health tech conference that explores the newest in digital health with eyes for what’s still to come. This year marked the first Health 2.0 conference since the show was acquired by HIMSS, MobiHealthNews's parent company.
With the four-day event come and gone, MobiHealthNews has collected all of its coverage from the Santa Clara Convention Center below, along with extra conference announcements and speaker discussions that might not have made it to the front page…
See also:
Health 2.0 Fall Conference Startup Pitch Competition: Meet the CompaniesBe up with some of my own conclusions shortly. Of particular interest to me were "Interoperability," 'Big Data & Analytics," "NLP," health care "policy," and "workflow."
This week, healthcare technology innovators, thought leaders, and business owners convene in Santa Clara, California for Health 2.0’s 11th Annual Fall Conference. While this year’s event runs from October 2-4, Medgadget was able to participate in the Sunday pre-conference and the annual Startup Pitch Competition.
Evaluating eight “Series A ready” companies, organized into professional solution (B2B) and consumer solution (B2C) tracks, were six judges…
UPDATE
Another fine recap, from the PoV of one of the Provider Symposium Day panelists:
Key Takeaways from Another Great Health 2.0Below, cool, someone had a fish-eye lense. Click the pic to enlarge,
Rasu Shrestha MD MBA
The Health 2.0 Conference gets better every year. I’m so grateful to have engaged with so many industry leaders – both familiar faces and new friends. What a wonderful opportunity to speak on the “Innovation to Implementation to Transformation” panel on Sunday and connect with people behind some of the most up-and-coming health care technology companies at MarketConnect Live. I also really enjoyed engaging with a ballroom full of enthusiastic attendees leading a lunch and learn discussion with my colleagues where we discussed best practices in marrying the competencies of a digital health company with the realities of patient care.
Sunday night’s Traction 2017 pitch competition was a highlight. I saw some promising startups that are using technology to solve long-standing health care problems. From skin cancer detection to new uses for 3D-printers, I saw innovations that reinforce UPMC Enterprises’ belief that technology can be an enabler of better, more efficient, and more affordable care.
While at Health 2.0, I thought a lot about where our industry is going and what each person’s role is in redefining the health care trajectory. I left the conference with three key takeaways I’d like to share with you…
Hmmm... I may need to buy one of those.
Also of note, from Joe Flower's opening Keynote:
"Six Assertions on Knowing the Unknowable Future of Healthcare"__
CODA
I've been mostly offline for a week, under the weather and dealing with my ailing daughter while my wife was in Florida on business. I don't have a lot to add the the assessments of the Conference, except to say that my irascible dubiety toward "interoperability" has been attenuated. I retain some misgivings, but it seems that the FHIR crowd is indeed making significant headway. Beyond that, my skeptical view of "NLP" pretty much remains intact, and I continue to view warily all the exuberant hype around the putative panacea of "big data."
____________
More to come...
No comments:
Post a Comment